Shares of DocuSign, Inc. (NASDAQ:DOCU - Get Free Report) have been given an average rating of "Hold" by the thirteen ratings firms that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $92.45.
Several equities research analysts have issued reports on the company. Wells Fargo & Company raised their price target on DocuSign from $50.00 to $70.00 and gave the company an "underweight" rating in a report on Friday, December 6th. Bank of America lifted their target price on shares of DocuSign from $60.00 to $68.00 and gave the stock a "neutral" rating in a report on Friday, September 6th. Hsbc Global Res upgraded shares of DocuSign to a "moderate sell" rating in a research note on Friday, December 6th. Morgan Stanley upped their target price on DocuSign from $62.00 to $97.00 and gave the company an "equal weight" rating in a research report on Friday, December 6th. Finally, Jefferies Financial Group lifted their target price on DocuSign from $80.00 to $95.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd.
Read Our Latest Report on DOCU
DocuSign Trading Up 3.5 %
Shares of DOCU traded up $3.35 during mid-day trading on Monday, reaching $97.83. The company's stock had a trading volume of 4,819,711 shares, compared to its average volume of 2,993,376. DocuSign has a 1-year low of $48.70 and a 1-year high of $107.86. The business has a 50-day simple moving average of $78.74 and a two-hundred day simple moving average of $63.71. The stock has a market cap of $19.76 billion, a P/E ratio of 20.17, a PEG ratio of 8.72 and a beta of 0.92.
Insider Buying and Selling
In other DocuSign news, CEO Allan C. Thygesen sold 7,648 shares of the company's stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $62.47, for a total value of $477,770.56. Following the completion of the transaction, the chief executive officer now owns 115,589 shares of the company's stock, valued at $7,220,844.83. This represents a 6.21 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Robert Chatwani sold 14,799 shares of DocuSign stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $55.46, for a total value of $820,752.54. Following the sale, the insider now directly owns 70,748 shares in the company, valued at $3,923,684.08. The trade was a 17.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 650,650 shares of company stock worth $60,848,626. Corporate insiders own 1.66% of the company's stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the company. Itau Unibanco Holding S.A. bought a new stake in DocuSign during the 3rd quarter worth approximately $28,000. Brooklyn Investment Group acquired a new stake in DocuSign in the third quarter valued at $33,000. Reston Wealth Management LLC bought a new position in DocuSign during the 3rd quarter worth $47,000. Wilmington Savings Fund Society FSB bought a new position in DocuSign during the 3rd quarter worth $51,000. Finally, nVerses Capital LLC acquired a new position in shares of DocuSign in the second quarter worth approximately $48,000. Institutional investors and hedge funds own 77.64% of the company's stock.
DocuSign Company Profile
(
Get Free ReportDocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.